Amisulpride, an atypical neuroleptic;Place de l'amisulpride dans la classe des neuroleptiques atypiques

Encephale

Volumn 22, Issue SPEC. ISS. 2, 1996, Pages 3-8

  Perrault, G ^a   Schoemaker, H ^a   Scatton, B ^a  

^a SANOFI   (France)

Author keywords

amisulpride; atypical antipsychotic; dopamine D 2 D 3 receptors blockade

Indexed keywords

AMISULPRIDE; APOMORPHINE; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PRESYNAPTIC RECEPTOR;

ANIMAL EXPERIMENT; BINDING AFFINITY; CONFERENCE PAPER; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; LIMBIC SYSTEM; LOCOMOTION; NONHUMAN; RAT; YAWNING;

ANIMALS; DEPRESSION; HUMANS; LIMBIC SYSTEM; NEUROLOGIC EXAMINATION; RATS; RECEPTORS, DOPAMINE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SULPIRIDE;

EID: 0029811203     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. CUDENNEC A, JOURDAIN D, ROBERT JP, SCATTON B, BENAVIDES J. Effet de l'amisulpride (Solian) sur la consommation céré brale régionale de glucose chez le rat. Encephale 1994 ; 20 : 366.
2. GUYON A, ASSOULY-BESSE F, BIALA Z, PUECH AJ, THIÉBOT MH. Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats. Psychopharmacology 1993; 110: 460-6.
3. KEBABIAN JW. CALNE DB. Multiple receptors for dopamine. Nature 1979; 277: 93-6.
4. 3 dopaminergic receptors may explain the atypical pharmacological profile of amisulpride, a new antipsychotic benzamide. X11th International Congress of Pharmacology «Dopamine 94 » Quebec, 1994.
5. PUECH AJ, RIOUX P, PONCELET M, BROCHET D, CHERMAT R, SIMON P. Pharmacological properties of new antipsychotic agents: use of animal models. Neuropharmacology 1981; 20: 1279-84.
6. 3 receptors. XIXth Congress. Neuropsychopharmacology 1994; 10(suppl 1): 242S.
7. SCHOEMAKER H, FAGE D, CARTER C, CLAUSTRE Y, OBLIN A, BIDET S et al. Amisulpride, a novel antipsychotic preferentially affects the limbic dopaminergic system in the rat. XIIth International Congress of Pharmacology « Dopamine 94 » Quebec, 1994.
8. 2 receptor. Eur J Pharmacol Molec Pharmacol S 1992; 225: 331-7.
9. 3) as a target for neuroleptics. Nature 1990; 347: 146-51.
10. VAIVA G, THOMAS P, DESBONNET P, DUTOIT D, BIANCHI DECAIX I, GOUDEMAND M et al. Débits sanguins cérébraux avant et après traitement par amisulpride à faibles doses dans les formes déficitaires de schizophrénie. Réunion de l'Association Française de Psychiatrie Biologie. Encephale 1994; 20: 368.
11. VASSE M, PROTAIS P, COSTENTIN J, SCHWARTZ JC. Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice. Naunyn-Schmiedebergs. Arch Pharmacol 1985; 329: 108-16.
12. 4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350: 610-4.